Literature DB >> 6547786

Assay of dermatan sulfate cofactor (heparin cofactor II) activity in human plasma.

U Abildgaard, M L Larsen.   

Abstract

An assay measuring the thrombin inactivating effect of human plasma in the presence of dermatan sulfate (DS) is described. Test plasma, diluted 1/50, is incubated with human thrombin in the presence of DS. Remaining thrombin is determined with chromogenic substrate 2AcOH . H-D-CHG-Ala-Arg-pNA. Three dilutions of reference plasma suffice and the standard curve is linear. Antithrombin III (AT) exerts a small (3-8%) effect in the assay. When test plasma contains heparin above 0.05 U/ml, this unspecific effect of AT increases, but it may be abolished by antibodies against AT. In a normal material (n = 50), the SD of DS cofactor activity was greater (15%) than that of AT (8.7%). DS cofactor was normal in hereditary AT deficiency and in 15 patients with deep venous thrombosis. In liver cirrhosis and in DIC, both inhibitors were markedly depressed, to similar degrees (r = 0.84).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547786     DOI: 10.1016/0049-3848(84)90357-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.

Authors:  B Bray; D A Lane; J M Freyssinet; G Pejler; U Lindahl
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate.

Authors:  G Mascellani; L Liverani; P Bianchini; B Parma; G Torri; A Bisio; M Guerrini; B Casu
Journal:  Biochem J       Date:  1993-12-15       Impact factor: 3.857

3.  Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency.

Authors:  D Valla; M H Denninger; J M Delvigne; B Rueff; J P Benhamou
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.